Vistin Pharma ASA: Second quarter and first half 2024 financial results
23 Agosto 2024 - 12:40AM
UK Regulatory
Vistin Pharma ASA: Second quarter and first half 2024 financial
results
Oslo, Norway, 23rd of August 2024
Vistin Pharma ASA (VISTN) today announces the financial results
for the second quarter of 2024.
Revenue in the second quarter ended at MNOK 106 compared to MNOK
107 in Q2 2023. Sales volume in the quarter was up by 4% compared
to Q2 2023, currency neutral sales increased by 1%. Revenue for
first half of 2024 ended at MNOK 210 compared to MNOK 208 YTD last
year.
Second quarter EBITDA ended at MNOK 27 compared to MNOK 20 in Q2
2023, representing a 40% increase. EBITDA positively affected by
product mix, favorable material cost prices and good cost control
in quarter. EBITDA for first half of 2024 ended at MNOK 48 compared
to MNOK 34 YTD 2023, an increase of 42%.
The net profit ended at MNOK 19.2 for the second quarter of
2024. Net profit positively affected with approx. MNOK 2.5 in the
quarter due to fair value of future FX cash flow hedging contracts
(unrealized gain - no cash effect in quarter).
Cash dividend of NOK 0.50 per share distributed in June 2024.
Additional dividend of NOK 0.50 per share planned to be distributed
in Q4
The second quarter conference call, which will be held today
23rd of August at 8.30am (CET), will be available via webcast and
audio through the following access points:
Webcast:
https://edge.media-server.com/mmc/p/v93s3oau
Telephone conference (online registration):
https://register.vevent.com/register/BIe6d25489e7ce45c18e8661e4d04d1d9a
The conference call will be held in
English.
Please find the Q2 report and presentation enclosed. The report
will also be made available on www.vistin.com.
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com
This information is subject to the disclosure requirements
pursuant to section 5-12 of the Norwegian Securities Trading
Act.
- Vistin Pharma ASA Q2 report 2024
- VistinPharma_Q2_24_presentation
Vistin Pharma Asa (LSE:0RAM)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Vistin Pharma Asa (LSE:0RAM)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
